These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6238156)

  • 21. Pharmacokinetics of a single intravenous dose of teicoplanin in subjects with various degrees of renal impairment.
    Bonati M; Traina GL; Rosina R; Buniva G
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():29-37. PubMed ID: 2965129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Teicoplanin binding in plasma following administration of increasing intravenous doses to healthy volunteers.
    Bernareggi A; Borgonovi M; Del Favero A; Rosina R; Gavanaghi L
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():256-60. PubMed ID: 1840325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacokinetics and tissue penetration of teicoplanin.
    McNulty CA; Garden GM; Wise R; Andrews JM
    J Antimicrob Chemother; 1985 Dec; 16(6):743-9. PubMed ID: 2936707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and bioavailability of a new formulation of teicoplanin following intravenous and intramuscular administration to humans.
    Antony KK; Lewis EW; Kenny MT; Dulworth JK; Brackman MB; Kuzma R; Yuh L; Eller MG; Thompson GA
    J Pharm Sci; 1991 Jun; 80(6):605-7. PubMed ID: 1834827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teicoplanin, its pharmacokinetics, blister and peritoneal fluid penetration.
    Wise R; Donovan IA; McNulty CA; Waldron R; Andrews JM
    J Hosp Infect; 1986 Mar; 7 Suppl A():47-55. PubMed ID: 2871097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical pharmacokinetics and tissue penetration of teicoplanin.
    Novelli A; Mazzei T; Reali EF; Mini E; Periti P
    Int J Clin Pharmacol Res; 1989; 9(3):233-7. PubMed ID: 2526102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of teicoplanin in subjects with varying degrees of renal function.
    Derbyshire N; Webb DB; Roberts D; Glew D; Williams JD
    J Antimicrob Chemother; 1989 Jun; 23(6):869-76. PubMed ID: 2527223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of teicoplanin during cardiopulmonary bypass surgery.
    Mini E; Mazzei T; Reali EF; Novelli A; Periti P
    Int J Clin Pharmacol Res; 1989; 9(4):287-92. PubMed ID: 2528510
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of teicoplanin in renal failure.
    Falcoz C; Ferry N; Pozet N; Cuisinaud G; Zech PY; Sassard J
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1255-62. PubMed ID: 2957955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of teicoplanin in critically ill patients with various degrees of renal impairment.
    Domart Y; Pierre C; Clair B; Garaud JJ; Regnier B; Gibert C
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1600-4. PubMed ID: 2963586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of [14C]teicoplanin in male rats after single intravenous dose.
    Bernareggi A; Cavenaghi L; Assandri A
    Antimicrob Agents Chemother; 1986 Nov; 30(5):733-8. PubMed ID: 2948443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis.
    Rybak MJ; Lerner SA; Levine DP; Albrecht LM; McNeil PL; Thompson GA; Kenny MT; Yuh L
    Antimicrob Agents Chemother; 1991 Apr; 35(4):696-700. PubMed ID: 1829880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of A40926 in rats after single intravenous and subcutaneous doses.
    Bernareggi A; Danese A; Cavenaghi L
    Antimicrob Agents Chemother; 1988 Feb; 32(2):246-9. PubMed ID: 3364946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of teicoplanin in burn patients.
    Potel G; Moutet J; Bernareggi A; Le Normand Y; Meigner M; Baron D
    Scand J Infect Dis Suppl; 1990; 72():29-34. PubMed ID: 2151064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Charge and lipophilicity govern the pharmacokinetics of glycopeptide antibiotics.
    Pitkin DH; Mico BA; Sitrin RD; Nisbet LJ
    Antimicrob Agents Chemother; 1986 Mar; 29(3):440-4. PubMed ID: 2940973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical pharmacokinetics of teicoplanin.
    Wilson AP
    Clin Pharmacokinet; 2000 Sep; 39(3):167-83. PubMed ID: 11020133
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Teicoplanin: a new glycopeptide antibiotic complex.
    Babul N; Pasko M
    Drug Intell Clin Pharm; 1988 Mar; 22(3):218-26. PubMed ID: 2966729
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population pharmacokinetics of teicoplanin in patients with endocarditis.
    Yu DK; Nordbrock E; Hutcheson SJ; Lewis EW; Sullivan W; Bhargava VO; Weir SJ
    J Pharmacokinet Biopharm; 1995 Feb; 23(1):25-39. PubMed ID: 8576842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative pharmacokinetics of glycopeptide antibiotics, and the influence of teicoplanin on granulocyte function.
    Lode H; Boeckh M; Höffken G; Kühn M; Gaffal H; Borner K; Koeppe P
    Scand J Infect Dis Suppl; 1990; 72():9-13. PubMed ID: 2151068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of aztreonam after intravenous infusion.
    Scully BE; Swabb EA; Neu HC
    Antimicrob Agents Chemother; 1983 Jul; 24(1):18-22. PubMed ID: 6684898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.